1-3 of 3
Sandra Van Wetering, PhD
Close
Sort by
Journal Articles

A Novel Dendritic Cell-Derived Vaccine in Multiple Myeloma

Rebecca Karp Leaf, MD, Dina Stroopinsky, PhD, Athalia Rachel Pyzer, MD, Ada M. Kruisbeek, PhD, Sandra Van Wetering, PhD, Abigail J. Washington, BA, Leandra Cole, BA, Myrna R. Nahas, MD, Salvia Jain, MD, Arie Apel, MD, Jon Arnason, MD, Ayad Hamdan, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD
Journal: Blood
Blood (2016) 128 (22): 4484.
https://doi.org/10.1182/blood.V128.22.4484.4484
Published: 2016
Journal Articles

Clinical and Immunological Results Of a Phase I/IIa Study Of Allogeneic Dendritic Cell (DC) Vaccination, An “off The shelf” Treatment To Prevent Or Delay Relapse In Elderly Patients With Acute Myeloid Leukemia

Arjan A van de Loosdrecht, MD, PhD, Sandra van Wetering, PhD, Saskia Santegoeds, Satwinder Kaur Singh, PhD, Malika Koppes, Anthony Hall, MD, Ada M. Kruisbeek, PhD, Tanja D. de Gruijl, PhD., Gert J. Ossenkoppele, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2651.
https://doi.org/10.1182/blood.V122.21.2651.2651
Published: 2013
Journal Articles

Expansion of AML Blasts Induces CD14 Expression and Facilitates Leukemic DC Development for Therapeutic Application In AML

Willemijn van den Ancker, Pepijn G.J.T.B. Wijnands, Theresia M. Westers, PhD, Hetty J. Bontkes, PhD, Sandra van Wetering, PhD, Ada M. Kruisbeek, PhD, Gert J. Ossenkoppele, MD, PhD, Tanja D. de Gruijl, PhD., Arjan A. Van de Loosdrecht, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2193.
https://doi.org/10.1182/blood.V116.21.2193.2193
Published: 2010